23 May 2013
Keywords: guilford, files, brain, cancer, treatment, pharmaceuticals, submitted
Article | 12 February 1996
Guilford Pharmaceuticals has submitted a New Drug Application to the US Food and Drug Administration for Gliadel wafer, its implantable ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.